Healthcare & Life Sciences IPO Advisory in India

S45 helps Indian healthcare and life sciences companies prepare for IPO with sector-specific readiness, drafting, pricing, and investor strategy. From hospital chains and diagnostics to pharma, biotech, and medical devices, we bring disciplined execution aligned with SEBI requirements, India’s evolving healthcare infrastructure, and the investor metrics that matter in public markets.

Healthcare IPO advisory team reviewing listing strategy

Our Healthcare & Life Sciences IPO Services

Sector-focused IPO advisory for Indian healthcare companies from readiness through listing and post-listing support.

IPO Readiness

Assess listing eligibility, governance, disclosures, financial controls, cap table structure, and Main Board versus SME fit for healthcare and life sciences issuers in India.

DRHP & Regulatory

Prepare DRHP and RHP materials, organise the data room, coordinate diligence, and manage SEBI-facing documentation with healthcare-specific disclosure depth.

Pricing & Distribution

Build valuation frameworks, map QIB, NII, HNI, retail, and anchor demand, and support bookbuilding with investor targeting tailored to healthcare businesses.

Demand Thesis

Validate likely investor appetite before mandate signing with cohort-level demand mapping, subscription pattern forecasts, and roadshow planning across key Indian cities.

Main Board IPO

Guide larger healthcare issuers through NSE and BSE Main Board preparation, institutional positioning, compliance planning, and full-cycle execution support.

SME IPO

Support eligible growth-stage healthcare companies pursuing NSE Emerge or BSE SME listings with faster timelines, market maker coordination, and liquidity planning.

IPO advisory process for healthcare companies

Our Healthcare IPO Advisory Process

Run Readiness and Route Assessment

We begin with an AI-powered readiness scan and sector review to assess eligibility, governance gaps, disclosure quality, and whether a Main Board or SME pathway fits your company’s scale, profitability, and timeline in India.

Build the Healthcare Equity Story

Prepare DRHP and Regulatory Workstreams

Map Demand and Price the Issue

Support Listing and After-Market IR

Trusted Execution Record

Success Stories

Track record built on disciplined IPO execution, investor demand mapping, and structured post-listing support.

"In our EPC and electricals business, the biggest worry is whether a banker will truly understand how work actually gets done, but with S45 that clarity came immediately. They grasped our contracts, receivables, working-capital cycles and project timelines faster than anyone we've worked with, and the entire process felt structured..."

Mr Jignesh Patel
Mr Jignesh Patel
The S45 Difference

Why Choose S45?

S45 combines sector expertise, AI-led workflows, and disciplined execution for healthcare IPOs in India.

Sector Depth

Healthcare-specific diligence covers payer mix, accreditation, regulatory status, and investor-facing KPI framing.

Execution Speed

Move from first call to signed mandate in 7 days with structured workflows.

Investor Reach

Mapped access to 50,000+ investors across India’s QIB, NII, HNI, retail, and anchor pools.

Regulatory Discipline

Built to support SEBI-facing execution with evidence-linked drafting and cleaner disclosure control.

Meet The India Team

Founders with operator and capital markets experience.

Portrait of Deepank Bhandari, Co-Founder of S45

Deepank Bhandari

Founder

Deepank is the Founder of S45, an AI native investment bank focused on closing the capital markets gap for India's best emerging businesses. He works with founders who have built real, scalable companies and helps them access structured capital and public markets with clear, disciplined execution.He brings over 14 years of experience across investment banking, private equity, quick commerce, fintech, supply chain and actuarial sciences, with operating and investing roles at Blinkit, 1mg, BNP Paribas and Alcazar Capital. Before S45, he built a fintech platform that raised 5 million dollars in seed funding and grew into a meaningful wealth tech and structured finance business, which ultimately evolved into the S45 mission.Having scaled one of his ventures 10x to 60 million dollars in ARR, he has seen how strong fundamentals can still be held back by a lack of fit with traditional capital. Too operational for new age venture capital, too early for large institutions and unwilling to over dilute for private equity. Those constraints shaped his view on how capital should work for founders, not the other way around. At S45, his focus is on empowering 1,000 entrepreneurs over the next few years with the capital, strategic guidance and operating support they need to grow into India's next generation of resilient, high growth, blue chip companies.

Portrait of Pankaj Harlalka, Co-Founder of S45

Pankaj Harlalka

Founder

Pankaj is the Co-founder of S45, bringing over two decades of experience in capital markets, merchant banking and corporate advisory. A Company Secretary by training, he began his career at Dolphin Laboratories before moving into merchant banking at Microsec India Limited in 2003, where he developed a deep specialization in public markets and corporate transactions. Over his 22 year career, he has helped lead more than 16 main board IPOs, executed over 25 takeovers and managed rights issues, buybacks, mergers and demergers across multiple sectors. He has worked closely with some of East India's most prominent listed companies, including Ramkrishna Forgings, Rupa, Emami, Haldia Petrochemicals and Centuryply, guiding them through key phases of growth and market expansion. In his most recent role, Pankaj was part of the investor relations team at Shyam Metallics and Energy Limited, gaining firsthand insight into how large corporates think about strategy, capital allocation and sustained market performance. Having seen both the decisions that create lasting value and the missteps that hold companies back, he has built a strong track record in advising mid sized businesses on capital raising, M&A and long term value creation. At S45, he focuses on guiding founders through strategic growth initiatives, identifying acquisition opportunities and opening access to India's public markets. He brings a deep belief in empowering high potential entrepreneurs and is committed to reshaping the capital markets journey for India's small and mid sized enterprises.

Portrait of Aman Singh, Co-Founder of S45

Aman Singh

Founder

Aman is the Co-founder of S45, where he focuses on investing in and scaling high growth businesses. His work sits at the intersection of capital, strategy and operations, helping founders move from early traction to durable, compounding growth. He began his entrepreneurial journey while still at IIT Delhi, founding SayF in his pre final year and growing it into a venture backed company with a multi million dollar business footprint. After SayF, he worked directly with the founders of a Bay Area SaaS startup backed by Khosla Ventures, leading strategic and growth initiatives across product, sales and operations. His experience spans fintech, consumer technology and enterprise SaaS, with a focus on building from zero to one and then scaling with discipline. Having built and advised companies through fundraising cycles, product pivots and execution challenges, Aman has developed a clear understanding of capital efficiency, growth levers and what it takes to build resilient businesses. Growing up in an Indian Army household shaped his approach to work, with a strong bias for action, adaptability and resilience. At S45, he works closely with founders to refine strategy, unlock new growth opportunities and navigate fundraising with confidence. With firsthand experience as a founder, he focuses on helping entrepreneurs build enduring, purposeful companies with long term value. Outside of work, he enjoys travelling, meeting interesting people and spending time with long form essays and non fiction.

Frequently Asked Questions

What does a healthcare IPO advisor do in India?

A healthcare IPO advisor helps companies prepare for listing by assessing readiness, shaping the equity story, coordinating DRHP drafting, supporting SEBI-facing workstreams, building valuation frameworks, and mapping investor demand. For healthcare issuers, this also means translating sector metrics like occupancy, ARPOB, sample volumes, regulatory approvals, and manufacturing compliance into disclosures investors can evaluate clearly.

Which healthcare businesses can use IPO advisory services in India?

How early should a healthcare company start IPO preparation?

Can S45 help with Main Board and SME healthcare IPOs?

How is valuation handled for a healthcare and life sciences IPO?

What healthcare-specific disclosures matter most in IPO preparation?

How long does the IPO advisory process usually take?

What happens after a healthcare company gets listed?

Still Have IPO Questions?

Speak with our team about readiness, route selection, and execution.

Trusted Signals

Awards and Recognition

SEBI lead manager partner trust badge

SEBI Lead Manager Partner

Execution with regulated merchant banker support

AI-native investment banking trust badge

AI-Native Platform

Technology-led IPO execution workflow

Institutional investor network trust badge

Institutional Investor Network

Mapped reach across investor categories

Discuss Your Healthcare IPO Strategy

Share your stage, listing goals, and timeline. We’ll review fit, likely pathway, and the workstreams needed to move toward a disciplined IPO process in India.

Contact Us Today

For immediate assistance, feel free to give us a direct call at +91 95879 52454.